Search

Your search keyword '"Goebels N"' showing total 116 results

Search Constraints

Start Over You searched for: Author "Goebels N" Remove constraint Author: "Goebels N"
116 results on '"Goebels N"'

Search Results

2. Modified recombinant human IgG1‐Fc is superior to natural IVIG at inhibiting immune‐mediated demyelination

3. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

8. Therapie der multiplen Sklerose

16. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

23. A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

24. Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

25. Der Einfluß von Muskelarbeit auf das Myosonogramm

26. Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study

27. Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

28. Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study

32. The role of autoimmune t lymphocytes in the pathogenesis of multiple sclerosis

33. Effects of dimethyl fumarate on neuroprotection and immunomodulation

34. Vignette.

35. Collateral Bystander Damage by Myelin-Directed CD8+ T Cells Causes Axonal Loss

36. Die Bedeutung löslicher TNF-Familienmitglieder für die multiple Sklerose

37. A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies.

38. Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity.

39. Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity.

40. Multimodal electrophysiological analyses reveal that reduced synaptic excitatory neurotransmission underlies seizures in a model of NMDAR antibody-mediated encephalitis.

41. Modified recombinant human IgG1-Fc is superior to natural intravenous immunoglobulin at inhibiting immune-mediated demyelination.

42. [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)].

43. Association of Retinal Layer Thickness With Cognition in Patients With Multiple Sclerosis.

44. Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS.

45. Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis.

47. [Ocrelizumab for treatment of multiple sclerosis].

48. N-Methyl-D-Aspartate Receptor Antibodies in Autoimmune Encephalopathy Alter Oligodendrocyte Function.

49. Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.

50. An Assay to Determine Mechanisms of Rapid Autoantibody-Induced Neurotransmitter Receptor Endocytosis and Vesicular Trafficking in Autoimmune Encephalitis.

Catalog

Books, media, physical & digital resources